SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-14-004429
Filing Date
2014-04-30
Accepted
2014-04-30 16:32:35
Documents
10
Period of Report
2014-06-26
Effectiveness Date
2014-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2219813zdef14a.htm DEF 14A 893268
2 G202915.JPG g202915.jpg GRAPHIC 17152
3 G1012795.JPG g1012795.jpg GRAPHIC 6628
4 G128130.JPG g128130.jpg GRAPHIC 61111
5 G17604.JPG g17604.jpg GRAPHIC 41613
6 G809030.JPG g809030.jpg GRAPHIC 28141
7 G389785.JPG g389785.jpg GRAPHIC 51880
8 G769446.JPG g769446.jpg GRAPHIC 211097
9 G23132CAI001.GIF g23132cai001.gif GRAPHIC 54565
10 G23132CAI002.GIF g23132cai002.gif GRAPHIC 55540
  Complete submission text file 0001047469-14-004429.txt   1622781
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26301 | Film No.: 14799305
SIC: 2834 Pharmaceutical Preparations